Advertisement
UK markets close in 1 hour 48 minutes
  • FTSE 100

    8,368.14
    +14.09 (+0.17%)
     
  • FTSE 250

    20,535.29
    +43.30 (+0.21%)
     
  • AIM

    782.63
    +2.80 (+0.36%)
     
  • GBP/EUR

    1.1611
    -0.0011 (-0.10%)
     
  • GBP/USD

    1.2496
    -0.0001 (-0.01%)
     
  • Bitcoin GBP

    48,899.65
    -628.19 (-1.27%)
     
  • CMC Crypto 200

    1,324.15
    +24.06 (+1.85%)
     
  • S&P 500

    5,181.95
    -5.72 (-0.11%)
     
  • DOW

    39,022.53
    -33.86 (-0.09%)
     
  • CRUDE OIL

    79.31
    +0.32 (+0.41%)
     
  • GOLD FUTURES

    2,325.80
    +3.50 (+0.15%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,655.49
    +157.11 (+0.85%)
     
  • CAC 40

    8,157.38
    +25.97 (+0.32%)
     

Announcing: Spire Healthcare Group (LON:SPI) Stock Increased An Energizing 117% In The Last Year

Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a lot more than 100%. Take, for example Spire Healthcare Group plc (LON:SPI). Its share price is already up an impressive 117% in the last twelve months. And in the last month, the share price has gained 4.0%. We note that Spire Healthcare Group reported its financial results recently; luckily, you can catch up on the latest revenue and profit numbers in our company report. On the other hand, longer term shareholders have had a tougher run, with the stock falling 18% in three years.

Check out our latest analysis for Spire Healthcare Group

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

During the last year Spire Healthcare Group saw its earnings per share (EPS) drop below zero. While this may prove temporary, we'd consider it a negative, so we would not have expected to see the share price up. It may be that the company has done well on other metrics.

ADVERTISEMENT

Unfortunately Spire Healthcare Group's fell 6.2% over twelve months. So the fundamental metrics don't provide an obvious explanation for the share price gain.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

earnings-and-revenue-growth
earnings-and-revenue-growth

We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So it makes a lot of sense to check out what analysts think Spire Healthcare Group will earn in the future (free profit forecasts).

A Different Perspective

It's good to see that Spire Healthcare Group has rewarded shareholders with a total shareholder return of 117% in the last twelve months. Notably the five-year annualised TSR loss of 8% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. Investors who like to make money usually check up on insider purchases, such as the price paid, and total amount bought. You can find out about the insider purchases of Spire Healthcare Group by clicking this link.

Spire Healthcare Group is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on GB exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.